113 related articles for article (PubMed ID: 17716229)
1. Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions.
Laskowitz DT; Vitek MP
Pharmacogenomics; 2007 Aug; 8(8):959-69. PubMed ID: 17716229
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease.
Laskowitz DT; Fillit H; Yeung N; Toku K; Vitek MP
Acta Neurol Scand Suppl; 2006; 185():15-20. PubMed ID: 16866906
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E and the CNS response to injury.
Laskowitz DT; Horsburgh K; Roses AD
J Cereb Blood Flow Metab; 1998 May; 18(5):465-71. PubMed ID: 9591838
[TBL] [Abstract][Full Text] [Related]
4. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
5. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.
Huang Y
Curr Opin Lipidol; 2010 Aug; 21(4):337-45. PubMed ID: 20531185
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E structure: insights into function.
Hatters DM; Peters-Libeu CA; Weisgraber KH
Trends Biochem Sci; 2006 Aug; 31(8):445-54. PubMed ID: 16820298
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E in the brain and its role in Alzheimer's disease.
Poirier J
J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
[TBL] [Abstract][Full Text] [Related]
9. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction.
Gromadzka G; Baranska-Gieruszczak M; Sarzynska-Dlugosz I; Ciesielska A; Czlonkowska A
Acta Neurol Scand; 2007 Dec; 116(6):392-8. PubMed ID: 17986098
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism and central nervous system tumors: correlation with cell proliferation indices and clinical outcome.
Zunarelli E; Nicoll JA; Trentini GP
Clin Neuropathol; 2000; 19(1):1-6. PubMed ID: 10774944
[TBL] [Abstract][Full Text] [Related]
11. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A.
Christensen DJ; Ohkubo N; Oddo J; Van Kanegan MJ; Neil J; Li F; Colton CA; Vitek MP
J Immunol; 2011 Feb; 186(4):2535-42. PubMed ID: 21289314
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
Kamboh MI
Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
[TBL] [Abstract][Full Text] [Related]
14. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass.
Grünenfelder J; Umbehr M; Plass A; Bestmann L; Maly FE; Zünd G; Turina M
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):92-7. PubMed ID: 15224026
[TBL] [Abstract][Full Text] [Related]
16. Impact of apoE genotype on oxidative stress, inflammation and disease risk.
Jofre-Monseny L; Minihane AM; Rimbach G
Mol Nutr Food Res; 2008 Jan; 52(1):131-45. PubMed ID: 18203129
[TBL] [Abstract][Full Text] [Related]
17. Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury.
Ziebell JM; Bye N; Semple BD; Kossmann T; Morganti-Kossmann MC
Brain Res; 2011 Sep; 1414():94-105. PubMed ID: 21871613
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism and outcome after mild to moderate traumatic brain injury: a study of patient population in India.
Pruthi N; Chandramouli BA; Kuttappa TB; Rao SL; Subbakrishna DK; Abraham MP; Mahadevan A; Shankar SK
Neurol India; 2010; 58(2):264-9. PubMed ID: 20508347
[TBL] [Abstract][Full Text] [Related]
19. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity.
Maezawa I; Jin LW; Woltjer RL; Maeda N; Martin GM; Montine TJ; Montine KS
J Neurochem; 2004 Dec; 91(6):1312-21. PubMed ID: 15584908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
